PCRX
NASD Pacira Biosciences, Inc.$25.65 ↑ +0.00 (+0.00%) Trading Up from the previous close of $25.65, $0.02 below the day’s high of $25.67
- YTD change
- -0.89%
- vs 20-day SMA
- +1.28%
- vs 200-day SMA
- +7.27%
Price ranges
Price & Performance
+2.12 (+9.11%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 68.8% away from all-time highs of $82.16
- PCRX is down 1% since the beginning of the year
- PCRX is up 1% over the past 12 months
- PCRX is down 0% over the past 1 month
- 20% of all PCRX investors are betting against PCRX
PCRX reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +0.2%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- +6.39%
- vs 8-day SMA
- +3.28%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Brisbane, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.